A point mutation in CD28 distinguishes proliferative signals from survival signals

Klaus Okkenhaug(Ontario Institute for Cancer Research), Linda Wu(Princess Margaret Cancer Centre), Kristine M. Garza(Ontario Institute for Cancer Research), José La Rose(Ontario Institute for Cancer Research), Wilson Khoo(Amgen (Canada)), Bernhard Odermatt(University of Zurich), Tak W. Mak(Ontario Institute for Cancer Research), Pamela S. Ohashi(Ontario Institute for Cancer Research), Robert Rottapel(Princess Margaret Cancer Centre)
Nature Immunology
April 1, 2001
Cited by 204

Abstract


Related Papers

No related papers found

Powered by citation graph analysis